These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 27737437)
1. Association Between Androgen Deprivation Therapy and Risk of Dementia. Nead KT; Gaskin G; Chester C; Swisher-McClure S; Leeper NJ; Shah NH JAMA Oncol; 2017 Jan; 3(1):49-55. PubMed ID: 27737437 [TBL] [Abstract][Full Text] [Related]
2. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer. Jayadevappa R; Chhatre S; Malkowicz SB; Parikh RB; Guzzo T; Wein AJ JAMA Netw Open; 2019 Jul; 2(7):e196562. PubMed ID: 31268539 [TBL] [Abstract][Full Text] [Related]
3. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database. Tae BS; Jeon BJ; Shin SH; Choi H; Bae JH; Park JY Cancer Res Treat; 2019 Apr; 51(2):593-602. PubMed ID: 30025445 [TBL] [Abstract][Full Text] [Related]
5. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer. Nguyen C; Lairson DR; Swartz MD; Du XL Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934 [TBL] [Abstract][Full Text] [Related]
6. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800 [TBL] [Abstract][Full Text] [Related]
7. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan. Huang WK; Liu CH; Pang ST; Liu JR; Chang JW; Liaw CC; Hsu CL; Lin YC; See LC JAMA Netw Open; 2020 Aug; 3(8):e2015189. PubMed ID: 32865575 [TBL] [Abstract][Full Text] [Related]
8. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer. Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635 [TBL] [Abstract][Full Text] [Related]
9. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model. Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180 [TBL] [Abstract][Full Text] [Related]
10. The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis. Sari Motlagh R; Quhal F; Mori K; Miura N; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF J Urol; 2021 Jan; 205(1):60-67. PubMed ID: 32856962 [TBL] [Abstract][Full Text] [Related]
11. Risk of dementia following androgen deprivation therapy for treatment of prostate cancer. Krasnova A; Epstein M; Marchese M; Dickerman BA; Cole AP; Lipsitz SR; Nguyen PL; Kibel AS; Choueiri TK; Basaria S; Mucci LA; Sun M; Trinh QD Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):410-418. PubMed ID: 31784699 [TBL] [Abstract][Full Text] [Related]
12. Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer. Baik SH; Kury FSP; McDonald CJ J Clin Oncol; 2017 Oct; 35(30):3401-3409. PubMed ID: 28841388 [TBL] [Abstract][Full Text] [Related]
13. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. Lonergan PE; Washington SL; Cowan JE; Zhao S; Broering JM; Cooperberg MR; Carroll PR J Urol; 2022 Apr; 207(4):832-840. PubMed ID: 34854749 [TBL] [Abstract][Full Text] [Related]
14. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Holliday EB; Kuban DA; Levy LB; Bolukbasi Y; Master P; Choi S; Nguyen Q; McGuire SE; Mahmood U; Frank SJ; Hoffman KE Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):389-394. PubMed ID: 28462945 [TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537 [TBL] [Abstract][Full Text] [Related]
16. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Messing EM; Manola J; Yao J; Kiernan M; Crawford D; Wilding G; di'SantAgnese PA; Trump D; Lancet Oncol; 2006 Jun; 7(6):472-9. PubMed ID: 16750497 [TBL] [Abstract][Full Text] [Related]
17. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study. Klil-Drori AJ; Santella C; Tascilar K; Yin H; Aprikian A; Azoulay L Drug Saf; 2019 Aug; 42(8):1005-1011. PubMed ID: 31240687 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer and risk of dementia. Robinson D; Garmo H; Van Hemelrijck M; Damber JE; Bratt O; Holmberg L; Wahlund LO; Stattin P; Adolfsson J BJU Int; 2019 Jul; 124(1):87-92. PubMed ID: 30637900 [TBL] [Abstract][Full Text] [Related]
19. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. Rusthoven CG; Jones BL; Flaig TW; Crawford ED; Koshy M; Sher DJ; Mahmood U; Chen RC; Chapin BF; Kavanagh BD; Pugh TJ J Clin Oncol; 2016 Aug; 34(24):2835-42. PubMed ID: 27325855 [TBL] [Abstract][Full Text] [Related]
20. Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study. Tae BS; Jeon BJ; Choi H; Bae JH; Park JY Cancer Med; 2019 Aug; 8(9):4475-4483. PubMed ID: 31183968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]